SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Aug 15, 2025, 3:49 PM
2.22
1.37%
After-hours: Aug 15, 2025, 04:00 PM EDT
SAB Biotherapeutics Fail-to-Deliver
Total FTD Shares
981
Below Average
FTD / Avg. Volume
0.07%
Low Impact
1-Year Change
96.6%
Positive Trend
FTD Chart
As of Jun 25, 2025,
SAB Biotherapeutics Inc. has
981
shares failed to deliver, representing 0.07%
of the average daily volume of
1,431,246
shares. Over the past year, the monthly average FTD is
13,524
shares, with the current level 93% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 25, 2025 | 1.82 | 981 | +2481.58% |
| May 29, 2025 | 1.81 | 38 | -98.75% |
| Apr 28, 2025 | 1.79 | 3.05K | +290.78% |
| Mar 28, 2025 | 1.48 | 781 | -16.56% |
| Feb 28, 2025 | 1.71 | 936 | -73.81% |
| Jan 30, 2025 | 2.17 | 3.57K | +915.34% |
| Dec 24, 2024 | 4.1 | 352 | -98.67% |
| Nov 29, 2024 | 2.92 | 26.39K | +942.96% |
| Oct 30, 2024 | 3.11 | 2.53K | +4188.14% |
| Sep 23, 2024 | 3 | 59 | +15.69% |
| Aug 30, 2024 | 2.94 | 51 | -98.67% |
| Jul 30, 2024 | 2.7 | 3.83K | +667.33% |
| Jun 18, 2024 | 2.58 | 499 | -38.09% |
| May 16, 2024 | 3.87 | 806 | +371.35% |
| Apr 19, 2024 | 4.29 | 171 | -98.07% |
| Mar 28, 2024 | 4.54 | 8.88K | +75.45% |
| Feb 29, 2024 | 4.46 | 5.06K | -95.56% |
| Jan 31, 2024 | 6 | 113.96K | +13.44% |
| Dec 29, 2023 | 6.88 | 100.46K | +3011.18% |
| Nov 27, 2023 | 8.8 | 3.23K | +124.55% |
| Oct 31, 2023 | 10 | 1.44K | +23.86% |
| Sep 26, 2023 | 5.11 | 1.16K | +4046.43% |
| Jul 17, 2023 | 8.5 | 28 | -83.03% |
| Jun 30, 2023 | 8.3 | 165 | +25.95% |
| May 31, 2023 | 8.9 | 131 | -98.32% |
| Apr 27, 2023 | 9 | 7.81K | +17.44% |
| Mar 31, 2023 | 4.4 | 6.65K | +421.74% |
| Feb 24, 2023 | 6.4 | 1.27K | +567.02% |
| Jan 23, 2023 | 7.02 | 191 | n/a |